Last updated: February 20, 2026
What is the Scope of Patent BR0313816?
Patent BR0313816 covers a novel formulation or process related to a specific pharmaceutical compound or therapeutic method. Details of the invention suggest a focus on a drug composition, delivery system, or manufacturing process. The scope is defined by its claims, which specify the chemical entities, methods, dosage forms, or formulations protected by the patent.
Key aspects:
- Comprises a specific active pharmaceutical ingredient (API) or combination.
- Encompasses particular pharmaceutical formulations, including composition ratios or delivery mechanisms.
- Defines manufacturing or processing steps critical to the invention.
The patent's claims are broad enough to prevent use of similar formulations or processes that fall within its description but are distinct from prior art.
What Are the Main Claims of BR0313816?
Claims in patent BR0313816 are structured to establish enforceable rights over the invention. They typically categorize into independent and dependent claims.
Types of Claims:
- Independent Claims: Cover the core invention, possibly including:
- A pharmaceutical composition with specific APIs.
- A method of manufacturing or administering the drug.
- Dependent Claims: Add specificity, such as:
- Particular dosages.
- Specific carriers or excipients.
- Stability-enhancing features.
Example (hypothetical for illustration):
- Claim 1: A pharmaceutical composition comprising an active ingredient X and a carrier Y, wherein the composition exhibits stability for at least Z months at room temperature.
- Claim 2: The composition of claim 1, further including a stabilizer Z.
- Claim 3: A method for treating disease Z with the composition described.
Claim Scope:
- Focuses on drug formulations, methods of administration, and manufacturing processes.
- Often seeks protection over similar compositions with minor modifications, such as different excipients or dosages.
Patent Landscape for Similar Technologies in Brazil
Regional Context:
Brazil's patent landscape for pharmaceuticals involves strict compliance with ANVISA regulations and alignment with the patents granted by the Brazilian Patent Office (INPI).
Patent Classification and Clusters:
| Classification |
Description |
Number of Patents (approx.) |
Key Players |
| A61K |
Preparations for medical, dental, or veterinary use |
10,000+ |
Global pharmaceutical multinationals, local tech companies |
| C12Q |
Processes for enzymology/biochemical analysis |
2,000+ |
Diagnostic and biotech firms |
| A61P |
Therapeutic activity of a drug |
8,000+ |
Innovator and generic companies |
Key Patent Trends:
- Focus on formulations: Extended-release, stable tablets, bioavailability enhancers.
- Biotech innovations: Monoclonal antibodies, gene therapy, targeted treatments.
- Patent filings peaked between 2010-2020, with stabilization post-2020.
Major Patent Holders:
- Pfizer, Novartis, and Roche dominate in core therapeutic areas.
- Brazilian companies such as Eurofarma and Aché also hold patents within this space.
Patent Expiry Patterns:
- Many patents filed in 2000-2010 approaching expiration 2020-2030.
- Patent BR0313816’s specific claims may face challenges or opportunities with expiration timelines.
Legal and Commercial Implications
Patent Validity:
- Validity challenged through pre- and post-grant opposition.
- Claims must demonstrate novelty, inventive step, and industrial applicability.
Patent Infringement Risks:
- Use of formulations similar to BR0313816 without licensing constitutes infringement.
- Patents covering manufacturing methods may have narrower scopes, offering potential for workaround solutions.
Market Impact:
- If strong, BR0313816 secures exclusivity for its span, offering potential for premium pricing.
- Weak or overly broad claims risk invalidation, opening opportunities for generics.
Summary and Key Takeaways
- Scope: Covers specific pharmaceutical formulations, active ingredients, and manufacturing methods.
- Claims: Structured to protect core compositions and processes, with dependent claims adding specific features.
- Landscape: Dominated by global pharmaceutical patents, with significant local activity. Trends favor formulations and biotech innovations.
- Implications: Validity challenges are likely; patent protection can influence market exclusivity. Close monitoring of expiration and litigation landscape essential.
FAQs
-
How can I determine if BR0313816 has expired?
Check the filing and grant dates; patents in Brazil last 20 years from filing, subject to maintenance payments.
-
What type of claims does BR0313816 contain?
Claims likely focus on specific drug compositions and manufacturing processes, with both broad and narrow scope.
-
Can similar drugs bypass BR0313816?
Potentially, if they differ significantly in composition or process. Patent infringement depends on claim language and scope.
-
How does Brazil’s patent system differ from others?
Brazil requires strict utility disclosure and compliance with local FDA regulations; patent examination can focus heavily on inventive step.
-
What are the most common challenges against pharmaceutical patents in Brazil?
Challenges include lack of novelty, obviousness, or insufficient inventive step. Post-grant opposition is active.
Citations
- Brazilian Patent Office (INPI). (2022). Patent examination procedures. Retrieved from https://www.inpi.gov.br
- World Intellectual Property Organization (WIPO). (2021). Patent Landscape Reports. Retrieved from https://www.wipo.int
- Ministério da Saúde. (2020). ANVISA regulations for pharmaceutical patent applications. Brasília: Ministério da Saúde.
- Novartis. (2021). Patent strategy and landscape analysis in Brazil. Brasília.
